ACCENT THERAPEUTICS, INC.
3Patents
3Active
3Granted
57Portfolio score
Filing activity: Mar 28, 2024 → Jan 14, 2025
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12233065B2 | Inhibitors of RNA helicase DHX9 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12391709B2 | Inhibitors of KIF18A and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12162867B2 | Inhibitors of RNA helicase DHX9 and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.